Ossiam Acquires 52,341 Shares of Laboratory Co. of America Holdings (NYSE:LH)

Ossiam increased its stake in Laboratory Co. of America Holdings (NYSE:LH - Free Report) by 2,051.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 54,892 shares of the medical research company's stock after purchasing an additional 52,341 shares during the quarter. Ossiam owned about 0.07% of Laboratory Co. of America worth $12,588,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Capital City Trust Co. FL boosted its holdings in Laboratory Co. of America by 1.5% in the 4th quarter. Capital City Trust Co. FL now owns 15,553 shares of the medical research company's stock valued at $3,567,000 after purchasing an additional 223 shares during the period. Wealthcare Advisory Partners LLC raised its position in shares of Laboratory Co. of America by 23.9% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 2,543 shares of the medical research company's stock worth $583,000 after buying an additional 490 shares in the last quarter. Bryn Mawr Capital Management LLC grew its position in Laboratory Co. of America by 51.2% during the fourth quarter. Bryn Mawr Capital Management LLC now owns 1,495 shares of the medical research company's stock worth $343,000 after buying an additional 506 shares in the last quarter. Barclays PLC increased its stake in Laboratory Co. of America by 11.8% in the 3rd quarter. Barclays PLC now owns 620,721 shares of the medical research company's stock worth $138,718,000 after acquiring an additional 65,356 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in Laboratory Co. of America by 7.0% in the 4th quarter. Nordea Investment Management AB now owns 1,052,927 shares of the medical research company's stock worth $243,321,000 after acquiring an additional 68,974 shares during the last quarter. 95.94% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Jefferies Financial Group increased their price target on shares of Laboratory Co. of America from $275.00 to $290.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Citigroup upgraded shares of Laboratory Co. of America from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $250.00 to $300.00 in a report on Tuesday, March 4th. StockNews.com lowered shares of Laboratory Co. of America from a "buy" rating to a "hold" rating in a report on Friday. Barclays lowered their price target on shares of Laboratory Co. of America from $260.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Finally, Evercore ISI raised Laboratory Co. of America from an "in-line" rating to an "outperform" rating and raised their price objective for the company from $260.00 to $265.00 in a research note on Tuesday, January 7th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $268.77.

Laboratory Co. of America Trading Down 2.2 %

LH traded down $4.69 during midday trading on Monday, reaching $212.43. 740,965 shares of the company's stock traded hands, compared to its average volume of 638,421. The stock has a market capitalization of $17.77 billion, a price-to-earnings ratio of 24.09, a P/E/G ratio of 1.71 and a beta of 0.99. Laboratory Co. of America Holdings has a 52 week low of $191.97 and a 52 week high of $258.59. The firm has a fifty day moving average of $236.97 and a two-hundred day moving average of $234.96. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.44 and a quick ratio of 1.30.

Laboratory Co. of America (NYSE:LH - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The medical research company reported $3.45 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.05. Laboratory Co. of America had a net margin of 5.73% and a return on equity of 15.29%. On average, equities analysts anticipate that Laboratory Co. of America Holdings will post 16.01 earnings per share for the current fiscal year.

Laboratory Co. of America Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Shareholders of record on Thursday, May 29th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 1.36%. Laboratory Co. of America's dividend payout ratio (DPR) is presently 32.65%.

Insider Buying and Selling at Laboratory Co. of America

In other Laboratory Co. of America news, CEO Adam H. Schechter sold 6,121 shares of Laboratory Co. of America stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $244.62, for a total transaction of $1,497,319.02. Following the completion of the transaction, the chief executive officer now owns 86,445 shares in the company, valued at approximately $21,146,175.90. The trade was a 6.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CMO Amy B. Summy sold 226 shares of Laboratory Co. of America stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $250.40, for a total value of $56,590.40. Following the completion of the transaction, the chief marketing officer now directly owns 4,544 shares of the company's stock, valued at approximately $1,137,817.60. This represents a 4.74 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,258 shares of company stock valued at $3,518,177. 0.84% of the stock is currently owned by corporate insiders.

Laboratory Co. of America Company Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.